What development phase is SPT-07A injection in?

SPT-07A injection is in Phase 3.

Last reviewed 2026-05-13 · How we verify

SPT-07A injection

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Phase 3 active Small molecule

SPT-07A injection's mechanism is not publicly available.

At a glance

Generic name	SPT-07A injection
Sponsor	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Modality	Small molecule
Phase	Phase 3

Mechanism of action

Unfortunately, there is limited information available on the mechanism of action of SPT-07A injection.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SPT-07A injection CI brief — competitive landscape report
SPT-07A injection updates RSS · CI watch RSS
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology portfolio CI